{"title":"Approach for the study of COVID-19 infection and vaccine development using mice model: A narrative review","authors":"Lismayana Hansur, M. Louisa, P. Wuyung","doi":"10.1063/5.0098285","DOIUrl":null,"url":null,"abstract":"COVID-19 global pandemics have called for researchers to design a suitable non-primate animal model as a tool for the study of pathogenesis, drug, and vaccine candidates. Studies using rodents have recently been developed and conducted to provide insights for various possible approaches to studying COVID-19. Here, we discussed the rodent model of COVID-19, primarily utilizing mice with strains of BALB/c and C57BL to understand the course of the and vaccine efficacy research. We searched for several online databases that studied the SARS-CoV-2 infection in rodents and vaccine development. We then appraised and discussed animal models to enhance drug development and vaccine studies on COVID-19. We appraised, discussed, and summarized 13 papers regarding the administration routes, observations, and indications for the study and further discussed the benefits and limitations of the studies. We found that researchers have successfully produced a transgenic animal model transfected with human ACE2 (hACE2), a good model of COVID-19 related high viral load with clinicopathology mimicking humans. We also found that the aged mice model presented a more serious disease than the less mature ones. Description and characterization of transgenic mice strains should also be applied to acquire a suitable animal model for COVID-19. Furthermore, SARS-CoV-2 has been shown to promote the number of pathogenic inflammation processes in BALB/c mice, which can be used for cytokines characterization, needed in drug and vaccine efficacy. © 2022 American Institute of Physics Inc.. All rights reserved.","PeriodicalId":193121,"journal":{"name":"THE 6TH BIOMEDICAL ENGINEERING’S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, AND MEDICAL DEVICES: Proceedings of the 6th International Symposium of Biomedical Engineering (ISBE) 2021","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"THE 6TH BIOMEDICAL ENGINEERING’S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, AND MEDICAL DEVICES: Proceedings of the 6th International Symposium of Biomedical Engineering (ISBE) 2021","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1063/5.0098285","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
基于小鼠模型的新型冠状病毒感染研究及疫苗研制方法综述
COVID-19全球大流行要求研究人员设计一种合适的非灵长类动物模型,作为研究发病机制、药物和候选疫苗的工具。最近开发并进行了啮齿动物研究,以提供研究COVID-19的各种可能方法的见解。本文以BALB/c和C57BL毒株小鼠为研究对象,探讨了新型冠状病毒啮齿动物模型,了解了新型冠状病毒疫苗疗效研究的过程。我们检索了几个研究啮齿动物中SARS-CoV-2感染和疫苗开发的在线数据库。然后,我们评估和讨论了动物模型,以加强COVID-19的药物开发和疫苗研究。我们评估、讨论和总结了13篇关于本研究的给药途径、观察结果和适应症的论文,并进一步讨论了研究的优点和局限性。我们发现,研究人员成功构建了转染人类ACE2的转基因动物模型(hACE2),这是一种与人类相似的COVID-19相关高病毒载量的良好模型。我们还发现,老年小鼠模型比不成熟小鼠模型出现更严重的疾病。转基因小鼠品系的描述和鉴定也需要应用于获得合适的COVID-19动物模型。此外,SARS-CoV-2已被证明可促进BALB/c小鼠的致病性炎症过程的数量,这可用于药物和疫苗功效所需的细胞因子表征。©2022美国物理学会。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。